Harm Reduction Journal

Article	Citations
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area	108
Accessing needle exchange services in disasters for remote areas of Aotearoa New Zealand	98
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	70
Assessment of knowledge and behaviors of an opioid overdose education and naloxone distribution program during the coronavirus disease 2019 pandemic	54
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	53
Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State	51
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	48
Acceptability of a pilot motivational interviewing intervention at public health facilities to improve the HIV treatment cascade among people who inject drugs in Indonesia	43
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021	41
Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking	41
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience	39
Motives for alcohol use, risky drinking patterns and harm reduction practices among people who experience homelessness and alcohol dependence in Montreal	37
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	37
The relationship between felt stigma and non-fatal overdose among rural people who use drugs	37
Contamination of a drug consumption room with drugs and potential risks for social health care workers	36
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA	36
Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia	36
Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study	36
Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs	34
Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users	34
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting	32
Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness	29
“It’s starting to weigh on me”: Exploring the Experiences and Support Needs of Harm Reduction Staff in Connecticut using the Social-Ecological Model	29
Awareness and willingness to use HIV self-testing among people who inject drugs in Iran	29
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa	29

The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada	28
Is peer support a tipping point for the opioid use disorder crisis in Appalachia? Research holds the answer	28
The “Gateway” hypothesis: evaluation of evidence and alternative explanations	26
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state	26
People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs!	25
A step change model analysis of the establishment of pill testing in one Australian jurisdiction	25
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study	25
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System	24
Mechanisms of resilience and coping to intersectional HIV prevention and drug-use stigma among people who inject drugs in rural Appalachian Ohio	23
Mind the G(ap): bridging prevention needs and approaches for GHB/GBL users and their social environment	23
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor	22
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	22
Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia	21
Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?	21
Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam	21
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	21
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland	20
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic	20
Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study	20
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	20
Harm reduction and its monitoring in Europe, from EMCDDA to EUDA	20
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users	19
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	19
Different phases of ATS use call for different interventions: a large qualitative study in Europe	18
Opioid-specific harm reduction in the emergency department: how staff provide harm reduction and contextual factors that impact their capacity to engage in harm reduction practice	18
Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?	18
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017	18
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020	18
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study	18
Interim opioid agonist treatment for opioid addiction: a systematic review	18
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	18
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation	18
The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19	18
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	17
The effect of different types of migration on symptoms of anxiety or depression and experience of violence among people who use or inject drugs in Kachin State, Myanmar	17
“Just another thing for me to stress off of”: Responses to unintentional fentanyl use in a community-based study of people who use opioids	16
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	16
Stigma and level of familiarity with opioid maintenance treatment (OMT) among specialist physicians in Israel	16
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises	16
Social and environmental determinants influencing injection drug use and HIV risk among two sister cities on the US–Mexico border: a comparative cross-sectional study, 2016–2018	16
“Wanna cry this out real quick?”: an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts	15
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t	15
Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study	15
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	15
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	15
Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA	15
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	15
People who use drugs and the right to health	15
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	14
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	14

Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	14
Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review	14
Developing an ethical framework for the recruitment of people who inject drugs experiencing incarceration in HIV prevention research: a qualitative study	14
An exploratory, randomised, crossover study to investigate the effect of nicotine on cognitive function in healthy adult smokers who use an electronic cigarette after a period of smoking abstinence	14
The underbelly of E-cigarette advertising: regulating online markets on social media platforms	14
Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	14
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse	14
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies	14
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study	13
Examining common mental health disorders in people living with HIV on methadone maintenance therapy in Hanoi, Vietnam	13
How post overdose response efforts can address social determinants of health among people who use drugs: perspectives from the New York State Department of Health (NYSDOH) Post Overdose Response Team	13
Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico	13
Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ proje	13
Expanding single-venue services to better engage young people who inject drugs: insights from India	13
Is expected substance type associated with timing of drug checking service utilization?: A cross-sectional study	13
Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada	13
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	13
Identifying the facilitators of Iran’s alcoholic beverage black market and presenting solutions for harm reduction: a qualitative document analysis	12
Decolonizing drug policy	12
Responding to a surge in overdose deaths: perspectives from US syringe services programs	12
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	12
Correction to: An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA)	12
Implementation and first-year operating costs of an academic medical center-based syringe services program	12
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study	12
Managed alcohol: one community’s innovative response to risk management during COVID-19	12
Correction: Co‑designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia	12
A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma	12
The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial	12
Decolonizing harm reduction	12
Is smokeless tobacco a healthier option in patients with AUD? A follow-up study during treatment	12
Correction: Using digital technology to reduce drug-related harms: a targeted service users’ perspective of the Digital Lifelines Scotland programme	12
Welfare first: transforming harm reduction at UK festivals	11
Correction: ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	11
“They're causing more harm than good”: a qualitative study exploring racism in harm reduction through the experiences of racialized people who use drugs	11
Reporting and methodological quality of systematic literature reviews evaluating the associations between e-cigarette use and cigarette smoking behaviors: a systematic quality review	11
A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes	11
Door-to-door overdose harm reduction: an Illinois case study	11
Challenges for the implementation of injectable opioid agonist treatment: a scoping review	11
Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs	11
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City	11
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	11
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia	11
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023–2024	11
Attitudes towards people who use substances: a survey of mental health clinicians from an urban hospital in British Columbia	11
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	10
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage	10
The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl	10
Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention	10
“There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction	10
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	10
Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study	10
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews	10
Perceptions, intentions, and actual use of a consumer nicotine gum	10
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report	10
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	10
Anonymous Opt-Out HIV and hepatitis C screening at a syringe services program in Florida	10
Differential risks of syringe service program participants in Central Ohio: a latent class analysis	10
The generative potential of mess in community-based participatory research with young people who use(d) drugs in Vancouver	10
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability	10
Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic	10
Testing the influence of harm reduction messages on health risk attitudes, injunctive norms and perceived behavioral control	10
Identifying drivers of increasing opioid overdose deaths among black individuals: a qualitative model drawing on experience of peers and community health workers	10
Association of hospital-based substance use supports on emergency department revisits: a retrospective cohort study in Sudbury, Canada from 2018 to 2022	10
Can alternative nicotine products put the final nail in the smoking coffin?	9
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	9
When it comes to assessing the impact of e-cigarettes, estimates of device prevalence matter: the BIDI Stick disposable device	9
Channelling and taxation in European online gambling markets: evolution and policy implications	9
Pharmacy-related syringe access barriers: an audit of Oregon community pharmacies	9
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context	9
Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process	9
Providers’ knowledge and perception of xylazine in the unregulated drug supply: a sequential explanatory mixed-methods study	9
Older adult drug overdose: an application of latent class analysis to identify prevention opportunities	9
Cannabis donation as a harm reduction strategy: a case study	9
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South	9
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study	9
Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review	9
Correction: Substance use, injection risk behaviors, and fentanyl‑related overdose risk among a sample of PWID post‑Hurricane Maria	9
The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cyc	9
Peer-led safer supply and opioid agonist treatment medication distribution: a case study from rural British Columbia	9
“It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply	9

Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	9
Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont	9
First results of the French OCTOPUS survey among festival attendees: a latent class analysis	9
Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study	9
Descriptive study: the novel “full spectrum people-with-opioid-use-disorder care model”	9
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care	8
Community alcohol sales and opioid poisoning deaths: Alcohol serving space as a harm reduction opportunity	8
Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?	8
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials	8
Facilitators and barriers to monitoring and evaluation at syringe service programs	8
Increases in housing rules and surveillance during COVID-19: impacts on overdose and overdose response in a community-based cohort of sex workers who use drugs in Vancouver, BC	8
Harm reduction must be recognised an essential public health intervention during crises	8
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	8
“It’s a delicate balance”: clinicians’ experiences of providing heroin-assisted treatment	8
Comparing professional communities: Opioid prescriber networks and Public Health Preparedness Districts	8
Substance use and overdose risk: documenting the perspectives of formerly incarcerated persons in the Fraser East region of BC	8
Utilization of drug checking services in Austria: a cross-sectional online survey	8
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	8
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland	8
Opioid overdose prevention education in Texas during the COVID-19 pandemic	8
Insights from the scale-up and implementation of the Deadly Liver Mob program across nine sites in New South Wales, Australia, according to the RE-AIM framework	8
“Prevention of opioid use disorder: the HOME (housing, opportunities, motivation and engagement) feasibility study”	8
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya	8
Implementing harm reduction kits in an office-based addiction treatment program	8